Why the study?
Does imipramine pharmacotherapy cause electrocardiographic abnormalities in children with behavior disorders?
Does imipramine pharmacotherapy cause electrocardiographic abnormalities in children with behavior disorders?
Imipramine use in children for behavior disorders is associated with electrocardiographic abnormalities such as first-degree AV block, necessitating careful clinical surveillance.
Answers are grounded in this paper and cite their sources.
Imipramine may be associated with AV block in children; case report leaves open need for ECG monitoring and causality.
The authors report seven cases of electrocardiographic abnormalities occurring in 7- to 10-year-old children receiving imipramine pharmacotherapy for behavior disorders. Three of the children evidenced a first-degree atrioventricular block. The abnormalities were less pronounced in the other four children. Imipramine plasma levels during steady state were not found to be directly related to the extent of the electrocardiographic changes within the obtained plasma values. The authors emphasize the necessity of careful clinical surveillance of children receiving imipramine pharmacotherapy.
No takes yet. Share an insight, caveat, or question.
Winsberg et al. (1975) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: